The World Health Organization has released a pre-publication note confirming that upcoming updates to its consolidated tuberculosis (TB) diagnostic guidelines will officially recognize tongue swabbing as an acceptable specimen type for molecular TB testing, marking a major shift in global diagnostic practices.
The note in brief:
- Tongue swabbing is a validated technique, especially useful for individuals who are unable to produce sputum.
- A new near-point-of-care NAAT category is introduced, allowing molecular testing at primary care and community health centers.
- Sputum pooling is endorsed as a cost-saving strategy for high-volume, resource-limited laboratories.
Tongue swabbing: broadening TB testing accessibility
Many people with TB - including a significant proportion of those who still contribute to transmission - are unable to produce sputum. Tongue swabs offer a non-invasive, patient-friendly alternative that can be collected by community health workers without specialist training.
Research spanning over a decade has established a strong evidence base for oral swab-based TB diagnostics. Multiple clinical studies using Copan FLOQSwabs® have demonstrated sensitive molecular detection of M. tuberculosis across many platforms, with reported sensitivities of 70–90% and specificities consistently near 100%. The WHO's formal recognition brings these field-tested workflows into the mainstream of national TB programs.
Broader diagnostic implications
The full second edition of consolidated TB diagnostic guidelines is expected later in 2026. Tongue swabbing, along with sputum pooling and near-point-of-care testing, will help lower barriers related to specimen collection, logistics, and infrastructure.
Learn More about TB diagnostics advancements and the evidence supporting tongue swab collection by global experts, visit the new Copan’s CoScience HUB chapter “Toward TB elimination: a contemporary perspective on epidemiology and diagnostics.”
